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a b s t r a c t
During early development, GATA factors have been shown to be important for key events of coronary
vasculogenesis, including formation of the epicardium. Myocardial GATA factors are required for
coronary vascular (CV) formation; however, the role of epicardial localized GATAs in this process has
not been addressed. The current study was conducted to investigate the molecular mechanisms by which
the epicardium controls coronary vasculogenesis, focusing on the role of epicardial GATAs in establishing
the endothelial plexus during early coronary vasculogenesis. To address the role of epicardial GATAs, we
ablated GATA4 and GATA6 transcription factors speciﬁcally from the mouse epicardium and found that
the number of endothelial cells in the sub-epicardium was drastically reduced, and concomitant
coronary vascular plexus formation was signiﬁcantly compromised. Here we present evidence for a
novel role for epicardial GATA factors in controlling plexus formation by recruiting endothelial cells to
the sub-epicardium.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The origin of coronary vascular (CV) endothelial cells has been
a longstanding topic of interest and investigation. It was initially
thought that coronary endothelial cells arose from the heart itself
(Manasek, 1969). Based on cell lineage tracing studies in avian
systems, an extra-cardiac structure derived from the septum
transversum termed the proepicardium (PE) was subsequently
proposed as the origin of CV endothelial cells (Mikawa and
Gourdie, 1996). These ﬁndings led to a model in which endothelial
precursor cells, along with other CV precursor cells, migrate from
the PE to the myocardium where they form the epicardium.
A subset of epicardial cells then invades the sub-epicardial space
to differentiate into the coronary endothelial cells, coronary
smooth muscle cells, and cardiac ﬁbroblasts that form the cor-
onary vasculature (Dettman et al., 1998; Merki et al., 2005;
Mikawa and Gourdie, 1996). The observation that blocking PE
attachment to the myocardium halted CV development supported
the idea that all CV cells are derived from the PE, including
vascular endothelial cells, or at least, that the PE is required for
differentiation of endothelial cells that make up the coronary
vasculature (Manner, 1993; Olivey et al., 2004). Recent murine
studies indicate that coronary endothelial cells have multiple
sources of origin and derive largely from the sinus venosus, the
PE, and the endocardium (Katz et al., 2012; Red-Horse et al., 2010).
The coronary vascular system consists of a network of coronary
arteries and coronary veins. The coronary arteries are generally
located within the myocardium, while the coronary veins are
typically located in the sub-epicardial space between the epicar-
dium and myocardium (Lavine and Ornitz, 2008). It was thought
that endothelial cells that contribute to the coronary arteries and
veins derived from separate sources within the developing heart
(Wu et al., 2012). However, recent work indicates that endothelial
cells, which contribute to both the coronary veins and the
coronary arteries, derive from the sub-epicardial endothelial cells
(SEECs) (Red-Horse et al., 2010; Tian et al., 2013). These ﬁndings
place the appearance of endothelial cells in the sub-epicardium as
a critical early step in coronary vascular formation.
Multiple studies indicate that formation of the endothelial CV
plexus involves complex reciprocal signaling between cells in the
epicardium and myocardial cells of the sub-epicardium (Lavine and
Ornitz, 2008; Olivey and Svensson, 2010; Tomanek et al., 2010).
Plexus formation has typically been used as the benchmark in
many of these studies; therefore, less has been done to distinguish
regulatory control mechanisms that are operating prior to plexus
formation. Formation of the coronary vascular plexus can be envi-
saged as having at least three steps: 1-migration and appearance of
endothelial cells or precursors in the sub-epicardium; 2-coalescence
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of vascular endothelial cells; and 3-assembly of the initial plexus.
Overall, plexus formation has been found to be dependent on
epicardial–myocardial reciprocal signaling that centers on an angio-
genic FGF-SHH-VEGF/Ang-2 signaling axis (Lavine and Ornitz, 2009).
The role of this axis in recruiting endothelial cells, mobilizing
resident hemangioblasts, or assembly of the initial plexus from
endothelial precursors is the topic of signiﬁcant investigation. In
the studies here, we present evidence that addresses GATA-
dependent regulatory control of these earliest steps and suggests a
model in which the epicardium is the source of signals that regulate
the appearance of SEECs.
The GATA family of transcription factors are important regulators
of vascular development (Lepore et al., 2005; Watt et al., 2004; Xin
et al., 2006; Zhao et al., 2005). The six members of the GATA family
are divided into two sub-groups based on their expression proﬁles
and roles in various developmental processes. GATA1/2/3 are
involved in hematopoietic development, while GATA4/5/6 regulate
cardiac and endodermal formation (Molkentin, 2000). Global knock-
out of either Gata4 or Gata6 results in failure of extra-embryonic
tissues leading to embryonic lethality during gastrulation, while
Gata5 knockouts were found to be viable (Koutsourakis et al., 1999;
Molkentin et al., 1997, 2000). Rescue of extra-embryonic tissue
failure by tetraploid complementation revealed that Gata4 knock-
outs are unable to form a PE, demonstrating a central role for GATA4
in CV development (Watt et al., 2004). Little is known concerning
the role of GATA6 in CV development; however, compound hetero-
zygous Gata4þ / Gata6þ / mice die at embryonic day 13.5 (E13.5)
due to vascular defects (Xin et al., 2006). This ﬁnding raises the
possibility that GATA4 and GATA6 are required for CV development.
Consistent with this idea, in vitro work has shown that GATA6 can
promote angiogenesis via suppression of anti-angiogenic, autocrine
signaling (Froese et al., 2011). Moreover, friend of GATA-2 (FOG-2) a
well-known GATA cofactor, has been found to be crucial for the
formation of the vascular plexus (Tevosian et al., 2000). These
ﬁndings suggest roles for GATA factors in coronary vascular devel-
opment and a more speciﬁc role for epicardial GATAs.
Here we address the role of GATA4 and GATA6 in epicardial-
mediated formation of the coronary plexus. Our results show that
GATA4 and GATA6 are expressed in the epicardium and required
for plexus formation. Using a Cre-lox system to conditionally
knock out both Gata4 and Gata6 (dcKO) in an epicardial-speciﬁc
manner, we found that the loss of epicardial GATAs resulted in a
drastic loss of coronary plexus formation. These results suggest
a model for formation of both coronary veins and arteries in which
epicardial GATAs regulate the number of endothelial cells in the
sub-epicardium.
Materials and methods
Animals
All animal experiments were approved by the Institutional
Animal Care and Use committee (IACUC) at the Medical College
of Wisconsin. The WT1(RP23-8C14)-Cre mouse line contains a BAC
expression construct in which the Cre recombinase gene was
inserted in the 50 UTR of the ﬁrst exon within the Wilms Tumor-
1 gene. This construct was designed to target the epicardium and
epicardial-derived cells. The WT1(RP23-8C14)-Cre line has been
maintained on a C57B16/J background and was obtained as a
generous gift from Dr. John Burch. The Gata4f/f/Gata6f/f mice were
generated by crossing the previously described Gata4f/f and Gata6f/f
mouse lines (Watt et al., 2004; Sodhi et al., 2006). The Gata4f/f line
contains loxP sites ﬂanking exons 3–5, which contain the nuclear
localization and DNA binding domains. The Gata6f/f line contains
loxP sites ﬂanking exon 2, which contains most of the GATA6
sequence. Tie2-Cre, Rosa26R-eYFP, and Rosa26R-βgal mice have
been previously described (Kisanuki et al., 2001; Soriano, 1999;
Srinivas et al., 2001).
Embryos were generated by timed matings designating E0.5
as noon on the day a vaginal plug was observed. Genotyping was
performed with PCR by standard protocols using genomic DNA
isolated from embryonic tail tissue.
Primers used are as follows:
Cre F: GTT CGC AAG AAC CTG ATG GAC A
R: CTA GAG CCT GTT TTG CAC GTT C
Gata4f/f F: CCC AGT AAA GAA GTC AGC ACA AGG AA
R: AGA CTA TTG ATC CCG GAG TGA ACA TT
Gata6f/f F: GTG GTT GTA AGG CGG TTT GT
R: ACG CGA GCT CCA GAA AAA GT
Histology and immunoﬂuorescence
Embryos were harvested from timed pregnant females, photo-
graphed, and ﬁxed overnight in zinc buffered formalin. Embryos
were then embedded in parafﬁn wax, and sectioned at 5 μm
according to standard protocols. Sections were then subject to
antigen retrieval with 10 mmol/L citric acid buffer (pH 6.0) at
100 1C for 10 min. Sections were then blocked for 45 min and
stained overnight with primary antibody in blocking solution.
Sections were then washed three times with PBS and incubated
with secondary antibody in blocking solution for 2 h. Finally,
sections were washed three times with PBS and incubated in
100 mmol/L glycine with DAPI for 1 h.
Sections were immunoﬂuorescently labeled according to stan-
dard protocols using anti-PECAM1 (1:100, BD Biosciences, clone
MEC13.3), anti-ERG (1:500, Santa Cruz Biotechnology, clone C-20),
anti-GFP (1:500, Invitrogen), anti-sarcomeric myosin (1:200,
DSHB, clone MF-20), anti-smooth muscle myosin heavy chain
(1:200, Biomedical Technologies BT-562), anti-GATA4 (1:100,
Santa Cruz Biotechnology, sc-9053), anti-GATA6 (1:5000, a gener-
ous gift from Dr. Xiang-Xi Xu), anti-WT1 (1:100, DAKO, 6F-H2) and
anti-SHH (1:100, DSHB, clone 5E-1) primary antibodies and
corresponding ﬂuorescent secondary antibodies from Invitrogen.
Images were captured using a Nikon Eclipse 80i microscope
equipped with a Nikon Digital Sight DS-2MBW monochrome
camera and NIS Elements-D imaging software. Photo processing
was done with Photoshop.
Whole-mount immunohistochemistry
Whole-mount PECAM staining was conducted as previously
described (Lavine et al., 2005). Isolated E12.5 hearts were ﬁxed
overnight in 4% paraformaldehyde. Following ﬁxation, hearts were
dehydrated with methanol and incubated in 6% hydrogen peroxide
for 2 h. Hearts were then rehydrated, blocked in 5% goat serum/1%
Triton X-100/PBS, and incubated overnight with PECAM primary
antibody (1:100, BD Biosciences, clone MEC13.3). Following 51 h
washes in blocking solution, hearts were incubated overnight with
biotinylated goat anti-rat IgG secondary antibody (1:200, Vector).
Following 51 h washes in blocking solution, hearts were incu-
bated overnight in ABC reagent (Vectastain). After a ﬁnal set of
washes, the hearts were then exposed to DAB and imaged. PECAM
stained hearts were then embedded, sectioned, lightly counter-
stained with hematoxylin, and imaged for quantiﬁcation of vessels
per section. Three sections from at least three wild type and three
dcKO hearts were used for quantiﬁcation.
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Lac-Z staining
Embryos were ﬁxed in 4% paraformaldehyde for 30 min on ice.
They were rinsed in wash buffer (0.1 mol/L phosphate buffer
(pH 7.3), 0.01% deoxycholate, 0.02% Nonidet-P40, 2 mmol/L MgCl2)
for 15 min at room temperature. They were then incubated over-
night in β-galactosidase substrate buffer (wash buffer plus
1 mg/mL X-gal, 5 mmol/L potassium ferrocyanide, 5 mmol/L potas-
sium ferricyanide). Embryos were then rinsed in wash buffer for
15 min at room temperature and then processed as listed above.
BrdU proliferation assay
Timed pregnant females were intraperitoneally injected 4 h
prior to harvest with 1 mL/100 g of BrdU labeling reagent (Invitro-
gen, 00-0103). Embryos were isolated, processed, and sectioned as
listed above. Sections were immunoﬂuorescently labeled accord-
ing to standard protocols using anti-BrdU (1:500, Invitrogen,
03-3900), Sarcomeric Myosin (1:200, DSHB, clone MF-20), and
Nkx2.5 (1:500, Santa Cruz Biotechnology, sc-8697) primary anti-
bodies and corresponding ﬂuorescent secondary antibodies.
Sections were counterstained with DAPI to label nuclei. For the
myocardial proliferation assay, four ﬁelds in the myocardium
consisting of ﬁfty Nkx2.5 expressing cells were counted for each
image. Three images were analyzed for each heart and three
hearts were quantiﬁed for each genotype.
Results
WT1(RP23-8C14)-Cre is expressed in the epicardium and epicardial-
derived cells.
To target the knockout of Gata4 and Gata6 in the epicardium
and epicardial derivatives, we utilized a WT1(RP23-8C14)-Cre
mouse transgenic line. Two other similar WT1-Cre lines have been
published, the WT280Cre YAC line and the WT1(RP23-266M16)-Cre
BAC line (Norden et al., 2010; Wilm et al., 2005). These previously
published WT1-Cre lines show Cre expression in the epicardium,
coronary smooth muscle cells, and a subset of adult coronary
endothelial cells (Norden et al., 2010; Wilm et al., 2005). To
characterize the expression of the WT1(RP23-8C14)-Cre used in
this study, WT1(RP23-8C14)-Cre mice were crossed with either the
Rosa26R-βgal reporter mice or the Rosa26R-eYFP reporter mice.
We observed that the WT1(RP23-8C14)-Cre was expressed in a
pattern similar to the previously published WT1-Cre lines (Norden
et al., 2010; Wilm et al., 2005). At E9.5, reporter expression was
seen in the proepicardium (Fig. 1A). At E10.5 epicardial expression
of the reporter was observed, and this continued through E14.5
(Fig. 1B and D). Reporter-expressing cells were observed migrating
into the myocardium at E12.5 (Fig. 1C). At E14.5 we saw extensive
reporter expression in the sub-epicardium and septum of the
developing myocardium (Fig. 1D). To determine the contribution
of eYFP-positive cells to coronary vascular cell types, we evaluated
expression of WT1(RP23-8C14)-Cre by co-staining with antibodies
against platelet endothelial cell adhesion molecule (PECAM) to
label coronary endothelial cells, and smooth muscle myosin heavy
chain (SM-MHC) to label coronary smooth muscle cells. At E12.5
before the appearance of coronary smooth muscle cells, we saw no
expression of the eYFP reporter in coronary endothelial cells
(Fig. 1E). At E14.5 we saw eYFP expression in coronary smooth
muscle cells and a few coronary endothelial cells (Fig. 1F). In
neonate hearts, we see continued expression of the reporter in
coronary smooth muscle cells and only occasional expression in
coronary endothelial cells (Fig. 1G). Additionally, we immunoﬂuor-
escently stained for eYFP and with an antibody against WT1, and
found 96% (70.5%) of the WT1 marked cells were eYFPþ at E12.5
(Supplemental Fig. 1). The expression pattern we observe is in
agreement with the expression pattern of other WT1 derived Cre
lines that showed reliable epicardial labeling and very rare
expression in endothelial cells (Wilm et al., 2005; Zhou et al.,
2009). These results are also consistent with previous observations
in other studies, which indicate that cells from the epicardium
largely give rise to coronary smooth muscle cells and ﬁbroblasts
and only occasionally to endothelial cells in mammals.
It has been suggested that a small percentage of cardiomyocytes
are derived from the epicardium, and previous reports with other
WT1 derived Cre0s have shown reporter expression in cardiomyoc-
tyes (Zhou et al., 2008). Therefore to further characterize the WT1
(RP23-8C14)-Cre, we also evaluated expression in cardiomyocytes.
We used Nkx2.5 as a marker for cardiomyocytes and co-stained for
eYFP (Fig. 1H and J). Consistent with other WT1 derived Cre0s, the
reporter was expressed in a sub-set of cardiomyocytes from E12.5 to
later times (Fig. 1H and J) (Rudat and Kispert, 2012). At E14.5 we
found eYFP labeled 14.03% (73.96%) of cardiomyocytes in the
septum and 4.96% (72.19%) of cardiomyocytes in the ventricular
walls. This suggests a small number of cardiomyocytes may derive
from the epicardium, or alternatively that the WT1(RP23-8C14)-Cre
could exhibit sporadic cardiomyocyte expression. The results in
Fig. 1 demonstrate that the expression pattern of WT1(RP23-8C14)-
Cre is similar to otherWT1 derived Cre lines (Wilm et al., 2005; Zhou
et al., 2008) and that this pattern of expression replicates the known
expression of endogenous WT1 in mesothelium-derived tissues
(Rudat and Kispert, 2012).
WT1(RP23-8C14)-Cre efﬁciently disrupts expression of GATA4 and
GATA6 in the epicardium
Previous work has shown GATA4 is highly expressed in the
epicardium and proepicardium (Watt et al., 2004), but the expres-
sion pattern of GATA6 in the epicardium was unknown.
To determine if GATA6 is expressed in the epicardium, we
immunohistochemically stained E12.5 and E13.5 wild type hearts
with an antibody against GATA6. We observed enriched epicardial
expression of GATA6 along with comparably lower levels of
myocardial expression (Fig. 2A and C). This, along with observa-
tions from Watt et al., demonstrates that both GATA6 and GATA4
are expressed in the epicardium at times critical for establishing
the coronary vasculature.
To determine if WT1(RP23-8C14)-Cre disrupts expression of GATA4
and GATA6 in the epicardium, we crossed WT1(RP23-8C14)-Creþ /
Gata4f/þ Gata6f/þ males with Gata4f/f Gata6f/f females to generateWT1
(RP23-8C14)-Creþ / Gata4f/f Gata6f/f (dcKO) mice. We then visualized
GATA expression in the hearts using antibodies against GATA4 or
GATA6.We observed a consistent decrease in the epicardial expression
of both factors by E12.5 (Fig. 2B and F). To conﬁrm the loss of GATA4
and GATA6 persisted in epicardial derived cells migrating into the
myocardium, we crossed WT1(RP23-8C14)-Creþ / Gata4f/þ Gata6f/þ
males with Gata4f/f Gata6f/f Rosa26R-eYFP f/f females generating dcKO
mice expressing the eYFP reporter. We stained E14.5 hearts and
observed a loss of GATA4 and GATA6 in eYFP expressing cells derived
from the epicardium (Supplemental Fig. 2). These results showedWT1
(RP23-8C14)-Cre is able to ablate expression of GATA4 and GATA6 in
the epicardium and epicardial derived cells. This then allowed us to
investigate the role of epicardial GATA4 and GATA6 in coronary
vascular development.
Deletion of Gata4 and Gata6 in WT1(RP23-8C14)-Cre mice results in
embryonic lethality by E15.5
To address the effects ofWT1(RP23-8C14)-Cre-driven conditional
knockout of Gata4 and Gata6 during development, we crossed WT1
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(RP23-8C14)-Creþ / Gata4f/þ Gata6f/þ males with Gata4f/f Gata6f/f
females to generate litters aged from E10.5 to weanling. Genotyping
revealed a normal Mendelian ratio of dcKO mice through E14.5 with
the observation that dcKO embryos exhibited hind limb polydactyly
(Supplemental Fig. 3). By E15.5 all dcKOs observed were in various
stages of necrosis, and no dcKO mice were found at weaning
(Table 1). In contrast, WT1(RP23-8C14)-Creþ / Gata4f/þ Gata6f/f
and WT1(RP23-8C14)-Creþ / Gata4f/f Gata6f/þ mice were viable at
Fig. 1. WT1(RP23-8C14)-Cre is expressed in the epicardium and epicardial derived lineages. The fate of cells expressing WT1(RP23-8C14)-Cre was determined by crossing
with Rosa26R-βgal (A)–(D) and Rosa26R-eYFP (E)–(J) mice. At E9.5 WT1(RP23-8C14)-Creþ cells are seen in the proepicardium ((A), arrow). At E10.5 (B) reporter expression is
observed in the epicardium. At 12.5 (C)WT1(RP23-8C14)-Cre continues to label the epicardium and sub-epicardial mesenchymal cells. At 14.5 (D)WT1(RP23-8C14)-Cre labels
cells of the epicardium, the sub-epicardium, and the myocardium. Co-staining with Rosa26R.eYFP (Green, (E)–(J)) found the majority of vascular eYPFþ cells co-stained with
the smooth muscle cell marker, smooth muscle myosin heavy chain (Blue, (E)–(G)) and occasional co-expression (arrowheads) with the endothelial cell marker, PECAM (Red,
(E)–(G)). Co-staining with the cardiomyocyte marker, Nkx2.5 (Red, (H)–(J)), found WT1(RP23-8C14)-Cre does express in a small population of cardiomyoctyes from E12.5
((H)–(J)) on. Scale bars in (A)–(D) represent 500 μm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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E15.5, with a small percentage observable at weaning. This indicates
WT1(RP23-8C14)-Cre-driven loss of both Gata4 and Gata6 results in
mid-gestational-lethality. In addition to epicardial expression, WT1
(RP23-8C14)-Cre shows some expression in other mesothelial
tissues and a small subset of cardiomyocytes (Fig. 1); therefore,
embryonic lethality cannot be unequivocally ascribed to the
epicardial loss of GATA4 and GATA6. However, E15 is a common
age of lethality among phenotypes with deﬁcient coronary vascular
formation, and our observations are consistent with a loss of
coronary vascularity as a primary cause of lethality (Conway et al.,
Fig. 2. WT1(RP23-8C14)-Cre disrupts expression of GATA6 and GATA4 in the epicardial and sub-epicardial cells. The epicardial expression of GATA6 and GATA4 was
visualized with immunoﬂuorescence for GATA6 (A)–(D) and for GATA4 (Red, (E)–(H)). GATA6 (A) and (C) and GATA4 (E) and (G) were found to be expressed in epicardial and
sub-epicardial cells of wild type hearts. In dcKO hearts, there is was an observable decrease in the epicardial expression of GATA6 (B) and (D) and GATA4 (F) and (H) when
compared to the wild type (A), (C), (E) and (G). Hearts were co-stained against sarcomeric myosin (Green) to visualize the myocardium and DAPI (Blue) to visualize nuclei.
Scale bars represent 50 μm. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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2003). Signiﬁcantly, however, survival of dcKO embryos to E14.5
allowed us to study the role of epicardial GATAs in plexus formation
during early coronary vascular development.
Loss of epicardial GATAs inhibits cellular proliferation in the heart
Epicardial function is crucial for maturation of the developing
myocardium (Lavine et al., 2005). Because we targeted the knock-
out of GATA4 and GATA6 to the epicardium, we assessed the effect
on the myocardium. In 33% of E13.5 dcKO hearts, we found
myocardial thinning greater than 2 standard deviations from the
mean of the wild type. Ventricular thickness in dcKO hearts that
displayed thinning was signiﬁcantly decreased compared to wild
type (po0.05, Fig. 3C). This suggests incomplete penetrance of
the thinning phenotype (Fig. 3A and B) possibly due to inherent
variations in the Cre-loxP system (Rajewsky et al., 1996). Myocar-
dial thinning during development is commonly associated with a
decrease in myocardial proliferation (Stuckmann et al., 2003).
To test if this was the case in the dcKO hearts, we utilized a BrdU
incorporation assay. In hearts that showed thinning, we found a
statistically signiﬁcant decrease in the percentage of BrdU positive
myocardial cells when compared to the wild type hearts (Fig. 3F).
Moreover, we did not observe an increase in myocardial apoptosis
(data not shown). Ultimately, these data suggest that loss
of epicardial GATAs can result in some loss of myocardial cell
proliferation, which may manifest as myocardial thinning. Since
there is minimal expression of the Cre in cardiomyocytes, these
observations are consistent with the observed thinning being due
to either defective epicardial signaling or plexus disruption.
Epicardial GATAs are required for the formation of the coronary
plexus
Defects in myocardial growth are often associated with deﬁ-
cient coronary vascular development. GATA4 and GATA6 have
been reported to be important for vascular development. GATA4
is required for the formation of the proepicardium, and GATA6 is
required in vascular smooth muscle cells (Lepore et al., 2005; Watt
et al., 2004). Moreover, global compound heterozygosity of both
Gata4 and Gata6 results in severe vascular defects (Xin et al.,
2006). To address whether epicardial GATA4 and GATA6 may be
important for coronary development, we assessed the effect of
their loss on coronary vascular formation.
During normal CV development, coronary endothelial cells
appear ﬁrst in the sub-epicardium near the base of the heart to
form the initial vascular plexus at E11. They then spread towards
Fig. 3. dcKO hearts display myocardial thinning and decreased proliferation. Hematoxylin and eosin staining was used to visualize the morphology of wild type (A) and dcKO
(B) hearts at E13.5. We observed myocardial thinning in dcKO hearts (B) when compared to wild type hearts (A). Measurement of left ventricle thickness revealed a
signiﬁcant decrease between dcKO hearts that displayed thinning and wild type hearts (n¼po0.05, (C)). To measure myocardial proliferation, BrdU incorporation (Green)
was quantiﬁed in Nkx2.5 (Red) expressing cardiomyocytes (D)–(E). We found a statistically signiﬁcant decrease (n¼po0.005) in the percentage of BrdU positive cells within
the myocardium of dcKO hearts when compared to wild type hearts (F). Images were counterstained with DAPI (Blue) to label nuclei. Error bars represent standard deviation.
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 1
dcKO is embryonic lethal by E15.5.
Age Total Expected dcKO G6 KO G4 KO
E10.5 41 5 6 5 6
E11.5 77 10 7 8 8
E12.5 51 6 5 3 5
E13.5 81 10 11 10 7
E14.5 59 7 11 9 4
E15.5 41 5 0 (4) 4 4
Weaning 48 6 0 2 1
Genotypic analysis of mouse embryos generated by crossing.
WT1(RP23-8C14)-Creþ //GATA-4f/þ/GATA-6f/þ males with GATA-4f/f/GATA-6f/f.
Values represent observed viable embryos at each embryonic day. (X)¼necrotic
embryos; dcKO¼WT1(RP23-8C14)-Creþ //GATA-4f/f/GATA-6f/f; G6 KO¼WT1(RP23-
8C14)-Creþ //GATA-4f/þ /GATA-6f/f; G4 KO¼WT1(RP23-8C14)-Creþ //GATA-4f/
f/GATA-6f/þ .
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the apex and migrate covering the heart by E14.5 (Olivey et al.,
2004). Therefore, we initially assessed plexus formation in dcKO
mice by whole mount staining of E13.5 hearts using an antibody
against platelet endothelial cell adhesion molecule (PECAM). Wild
type hearts demonstrated an organized plexus covering the
majority of the heart (Fig. 4A). In marked contrast, the dcKO
hearts show limited plexus formation near the base of the heart
but spreading towards the apex is severely diminished (Fig. 4E).
Sections of whole mount PECAM stained hearts further conﬁrmed
decreased plexus coverage of the heart due to the loss of GATA4
and GATA6 (Fig. 4B, D and F–H). Moreover, quantiﬁcation con-
ﬁrmed an 80% decrease in the number of vessels per section in the
dcKO (po0.05, Fig. 4I). These results demonstrate that epicardial
GATA4 and GATA6 are crucial for proper formation of the coronary
plexus.
Epicardial GATA4 and GATA6 are required for the appearance of sub-
epicardial endothelial cells
We reasoned that this decrease in plexus formation might be
due to a decrease in the number of sub-epicardial endothelial
cells (SEECs) that directly contribute to formation of the plexus.
To quantify the changes in the number of SEECs, we visualized
endothelial cells by immunoﬂuorescent detection of ETS-related
gene (ERG), which labels the nuclei of endothelial cells (Fig. 5A and
D, Supplemental Fig. 4 showing ERG co-expression with both PECAM
Fig. 4. dcKO hearts exhibit decreased coronary plexus formation. Whole mount PECAM staining was used to visualize the formation of the coronary plexus at E13.5 (A) and
(E). dcKO hearts (E) display decreased coverage of the ventricle when compared to wild type hearts (A). Sections prepared from whole mount PECAM stained hearts were
used to visualize the formation of the coronary plexus at E13.5 (B)–(D), (F)–(H). Wild type hearts (B) display extensive sub-epicardial vessel formation, while dcKO hearts
(F) show very few vessels. Higher magniﬁcation of outlined boxes in whole section images show vessels at the base of both wild type (C) and dcKO hearts (G); however, the
spreading of vessels towards the apex of the wild type heart (D) is not replicated in the dcKO (H). Black arrowheads (C), (D), (G) and (H) mark sub-epicardial vessels.
Decreased PECAM signal in endocardium (B)–(D) and (F)–(G) is due to limited penetrance of whole mount staining. (I) Quantiﬁcation of vessels per section revealed a
statistically signiﬁcant (n¼po0.05) decrease in dcKO hearts when compared to wild type hearts. Error bars represent standard deviation. Scale bars represent 500 μm.
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and Tie2, well-established markers of endothelial differentiation)
(Nikolova-Krstevski et al., 2009). To distinguish cells of the sub-
epicardium and epicardium, we labeled the myocardiumwith MF20.
Sub-epicardial and epicardial cells were identiﬁed as cells exterior to
the myocardium.We determined the percentage of SEECs by dividing
the number of ERGþ cells in the sub-epicardium by the total number
of epicardial and sub-epicardial cells. Compared to wild type, we
observed an 80–90% decrease in the percentage of SEECs at E13.5 and
E14.5 in dcKO hearts (Fig. 5E and F), consistent with the decrease
seen in plexus formation. We also assessed the potential loss
of SEECs in the WT1(RP23-8C14)-Creþ / Gata4f/þ Gata6f/f and WT1
(RP23-8C14)-Creþ / Gata4f/f Gata6f/þ hearts and found a statistically
signiﬁcant decrease in both at E13.5 (Fig. 5E). However, the loss of
SEECs was not as severe as observed in the dcKO. Together, the
results in Figs. 4 and 5, demonstrate epicardial expression of both
GATA4 and GATA6 is required for proper formation of the endothelial
coronary plexus, and further suggest that this occurs through a
mechanism that involves a decrease in the number of SEECs.
The loss of SEECs disrupts the appearance of inner-myocardial
endothelial cells
Recent ﬁndings have shown that SEECs are major contributors to
the endothelium of the coronary arteries within the myocardium
Fig. 5. dcKO hearts exhibit decreased SEECs and inner-myocardial endothelial cells. The presence of SEECs was observed by immunoﬂuorescent labeling of endothelial cells
with an anti-ERG antibody (Red, (A)–(D)). We determined the percentage of SEECs by counting the number of SEECs and dividing that value by the total number of epicardial
and sub-epicardial cells. We observed a signiﬁcant decrease in the percentage of sub-epicardial endothelial cells in the dcKO hearts (B) and (D) when compared to the wild
type hearts (A) and (C). This decrease was found to be statistically signiﬁcant (n¼po0.005) at both E13.5 (E) and E14.5 (F). Additionally, we found decreases in the
percentage of SEECs in WT1(RP23-8C14)-Creþ / Gata4f/f Gata6f/þ (4f/f 6f/þ) and WT1(RP23-8C14)-Creþ / Gata4f/þ Gata6f/f hearts(4f/þ 6f/f, (E)–(F), n¼po0.005). (G) dcKO
hearts display a statistically signiﬁcant (n¼po0.05) decrease in the number of inner-myocardial endothelial cells at E13.5. Hearts were co-stained against sarcomeric myosin
(MF20, Green) to visualize the myocardium and DAPI to label nuclei. All scale bars represent 50 μm. Error bars represent standard deviation. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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wall (Tian et al., 2013). Loss of SEECs should, therefore, result in a
decrease of inner-myocardial endothelial cells. To test this hypoth-
esis, we labeled the inner-myocardial endothelial cells using
antibodies against the endothelial speciﬁc transcription factor
ERG (Nikolova-Krstevski et al., 2009). The percentage of inner-
myocardial endothelial cells was then determined by dividing the
number of ERG labeled nuclei in the basal half of the compact zone
by the total number of nuclei in same region. We observed a 3
fold decrease in the number of inner-myocardial endothelial cells in
the dcKOs when compared to the wild type hearts (Fig. 5G). This
result conﬁrms that the loss of epicardial GATA4 and GATA6 not
only affects the appearance of SEECs, but also the appearance of
inner-myocardial endothelial cells.
The direct loss of GATA4 and GATA6 in endothelial cells
Loss of GATA4 and GATA6 in our experiments is largely
conﬁned to the epicardium, suggesting that the resultant decrease
in SEEC numbers is due to signaling defects between the epicar-
dium and surrounding cells. However, Fig. 1 also shows that loss of
GATAs occurs in a small subset of SEECs. This raises the possibility
that direct effects on SEECs may account for the decrease in the
total number of SEECs observed in the dcKO. To begin to address
this, we quantiﬁed the percentage of SEECs expressing the WT1
(RP23-8C14)-Cre reporter. At E13.5 and E14.5, we observed
approximately 20% of SEECs were eYFPþ (Fig. 6A and C), whereas
dcKO animals showed an 80–90% loss of SEECs. These results
indicate that GATA loss is observed in only a small number of
SEECs, theWT1(RP23-8C14)-Cre expressing subset, and therefore is
unlikely to fully account for the observed loss of total SEECs. We
also assessed the percentage of SEECs that were labeled with the
eYFP reporter in the dcKO and found it was decreased 30%
(Fig. 6C), signiﬁcantly less than the total 80–90% loss of SEECs.
Together these observations indicate that GATA4 and GATA6 may
be autonomously required by SEECs. However, the direct knockout
of GATAs in a subset of SEECs does not fully account for the total
loss of SEECs observed in the dcKO animals, supporting a model in
which epicardial cells indirectly control SEEC number.
To address whether the WT1(RP23-8C14)-Cre expressing subset
of SEECs may disproportionately contribute to plexus formation,
we examined the proportions of WT1(RP23-8C14)-Cre expressing
SEECs at E13.5 and found that they contributed at most 20% of the
population. We also examined whether this WT1(RP23-8C14)-Cre
expressing population may be more proliferative than other
SEECS. We measured the proliferation rates of the WT1(RP23-
8C14)-Cre expressing and non-expressing populations at E12.5 and
found no signiﬁcant change in the proliferation rates (Fig. 6D).
Additionally, we did not observe an increase in apoptosis of SEECs
(data not shown). This data, along with the signiﬁcant loss of
GATAs in the epicardium but only in a small sub-set of SEECs, is
consistent with a model in which epicardial GATA4 and GATA6
may regulate epicardial signaling pathways needed for the appear-
ance, or an increase in number, of sub-epicardial endothelial cells,
and thereby the formation of the early vascular plexus.
dcKO does not alter the number of epicardial cells
To address whether loss of epicardial GATA4 and GATA6 may
result in loss of epicardial derived endothelial precursors and that
this may account for the drastic loss of SEECs, we counted the total
number of epicardial and sub-epicardial cells in the dcKO animals.
Fig. 6. WT1(RP23-8C14)-Cre expression is limited in SEECs. Embryos generated from
mating WT1(RP23-8C14)-Cre mice with Rosa26R-eYFP reporter mice were stained with
antibodies against eYFP (Green) and ERG (Red) to label endothelial cells. At E13.5 (A) and
E14.5 (B) we observed eYFP negative SEECs along with a few eYFP positive, SEECs
(arrows). The percentage of eYFPþ SEECs was found to be 16.89% at E13.5 and 19.58% at
E14.5 (C). At E13.5, we found a statistically signiﬁcant decrease in the percentage of
SEECs in dcKO hearts when compared to wild type hearts (n¼po0.005, (C)). We found
no signiﬁcant difference in the proliferation rates between eYFPþ and eYFP SEECs at
E12.5 (D). All scale bars represent 50 μm. Error bars represent standard deviation. (For
interpretation of the references to color in this ﬁgure legend, the reader is referred to the
web version of this article.)
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We ﬁrst counted the number epicardial and sub-epicardial cells
per mm of the epicardium. We observed a signiﬁcant decrease
(25 cells/mm) in the number of epicardial and sub-epicardial
cells of dcKOs (Fig. 7A). We then analyzed if the decease in
epicardial and sub-epicardial cells was due to a loss of epicardial
cells or SEECs. We used theWT1(RP23-8C14)-Cre driven reporter to
label epicardial cells in the wild type and dcKO cells and found no
difference in the number of epicardial cells per mm (Fig. 7B). We
then counted the number of SEECs per mm and found a signiﬁcant
decrease (20 cells/mm, Fig. 7C). This agrees with previous data
in Fig. 5 showing a decrease in the percentage of SEECs. Together,
these data indicated that even though loss of GATAs occurred
primarily in epicardial cells, there was not signiﬁcant change in
the number of epicardial cells. There is, however, a signiﬁcant loss
in the number of SEECs. This further supports the hypothesis that
loss of GATA4 and GATA6 in epicardial cells disrupts an epicardial
signaling mechanism that may be required for accumulation
and/or recruitment of SEECs.
Discussion
In this report, we investigated the role of epicardial GATA4 and
GATA6 during early CV development. Previous work has shown
that GATAs are required for the formation of the epicardium, and
that myocardial GATA factors are important in CV formation;
however, no role for GATAs in epicardium function had been
determined (Watt et al., 2004). Our results show that epicardial
GATA4 and GATA6 play a critical role in CV formation, and that
they are required for the formation of the coronary plexus. It is
interesting that the CV phenotype is most severe upon epicardial
loss of both GATA4 and GATA6. This is consistent with a model in
which GATA4 and GATA6 can functionally compensate for each
other (Molkentin et al., 1997). GATA4 and GATA6 are similar factors
that share a very high degree of sequence conservation, can
interact with a shared binding motif, and can regulate similar
target genes (Molkentin et al., 1997; Nemer and Nemer, 2003;
Pikkarainen et al., 2004). Moreover, whole embryo knockouts
of Gata4 demonstrated elevated levels of GATA6, suggesting
an in vivo compensatory response (Molkentin et al., 1997). This
redundancy has been shown in multiple developmental systems,
and our results add coronary vasculogenesis to this roster
(Park et al., 2009; Xin et al., 2006).
While the origin of CV endothelial cells is still not clear, recent
models have described predominantly non-epicardial sources for
SEECs (Katz et al., 2012; Red-Horse et al., 2010). SEECs were
originally thought to arise from the myocardium and endocardium
(Viragh and Challice, 1981). Subsequent lineage-tracing studies in
the chick suggested the epicardium as a source for coronary
endothelial cells (Mikawa and Gourdie, 1996). More recent mouse
studies suggest the sinus venosus, endocardium, and proepicar-
dium as source tissue, and that each contribute in varying degrees
to the coronary endothelial population with only a very minor
contribution from the epicardium (Red-Horse et al., 2010; Cossette
and Misra, 2011; Katz et al., 2012). In our experiments we
observed that the WT1(RP23-8C14)-Cre -driven reporter reliably
labeled the entire epicardium but only 20% of SEECs (Fig. 5).
Further, expression of the Cre reporter used here is only seen in a
small subset of endothelial cells in developed vessels (Fig. 1). The
observation that the preponderance of epicardial cells express the
Cre reporter while only a small subset of the coronary endothelial
cells express the reporter is consistent with models in which the
majority of the coronary endothelial cells are not derived from the
epicardium (Katz et al., 2012; Red-Horse et al., 2010; Wilm et al.,
2005; Zhou et al., 2008). Our observations, however, are consistent
with a model in which the epicardium generates GATA dependent
signals to recruit endothelial cells from the sinus venosus and/or
PE to the sub-epicardium.
The epicardium is a source of many signaling factors required
for cardiac and CV development. Studies directly inhibiting epi-
cardial signaling have found defects in epicardial adhesion, myo-
cardial formation, and CV formation (Olivey and Svensson, 2010).
Based on factors known to be secreted from the epicardium,
we hypothesized that epicardial sonic hedgehog (SHH) may be
affected in the dcKO (Lavine et al., 2006). We analyzed hedgehog
Fig. 7. dcKO does not affect the number of epicardial cells. The number of
epicardial and sub-epicardial cells was quantiﬁed by counting the number of nuclei
per mm exterior to the myocardium this revealed a signiﬁcant decrease in the dcKO
hearts when compared to the wild type hearts ((A), n¼po0.005). Epicardial cells
were labeled with the WT1(RP23-8C14)-Cre driven Rosa26R-eYFP reporter and
counted per mm to determine no signiﬁcant difference between the wild type
and dcKO mice at E13.5 (B). SEECs were labeled with ERG and counted per mm to
determine a signiﬁcant decrease between the wild type and dcKO hearts ((C),
npo0.005). Error bars represent standard deviation.
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expression using a monoclonal antibody raised against the N-
terminus of SHH and observed a loss of SHH in the sub-epicardium
of dcKO hearts (Ericson et al., 1996) (Supplemental Fig. 5A and B),
suggesting that GATA-dependent epicardial hedgehog signaling
pathways control SEEC numbers. Consistent with an important
role of SHH, we found that we could rescue the loss of SEECs in an
ex vivo assay by supplementation with exogenous SHH, thereby
rescuing the phenotype (Supplemental Fig. 5E and F). While these
ﬁndings strongly support the hypothesis that epicardial GATAs
recruit endothelial cells in to the sub-epicardial space via SHH, we
were unable to ﬁnd a signiﬁcant difference in the levels of shh
mRNA between the wild type and dcKO (Supplement Fig. 4G). The
reason for this discrepancy is unclear. GATAs may not directly
regulate transcription of the shh gene, but rather may be involved
in post-transcriptional regulation of shh. Alternatively, the SHH
antibody may be cross-reacting with other epitopes. However,
rescue experiments using exogenous SHH support a central role
for SHH and are in agreement with the loss of SHH seen in the
antibody results (Supplemental Fig. 5C and F). Alternatively,
the SHH antibody we used does detect the other members of
the hedgehog family, Indian hedgehog and Desert hedgehog
(Ericson et al., 1996), and loss of antibody signal in the dcKO could
be due to changes in the expression of non-sonic hedgehogs.
However, SHH is thought to be the only signiﬁcant hedgehog in
coronary vascular development, and Indian and Desert hedgehog
are known to be expressed at very low levels (Lavine et al., 2006).
Future work will have to address more carefully the potential
relationship between epicardial GATAs and SHH signaling, or other
signaling pathways that may control SEEC accumulation and early
plexus formation.
In summary, we have established for the ﬁrst time in this study
that GATA4 and GATA6 are expressed in the epicardium during
coronary vascular development. We have also presented evidence
that epicardial GATAs play a critical role in the establishment of
the coronary vasculature by regulating the number of SEECs
during early plexus formation. In addition, based on the model
proposed in Lavine et al., 2006, in which epicardial SHH plays a
key signaling role in establishing the coronary plexus, results
presented in Supplemental Fig. 5 support a role for GATA4 and
GATA6 in regulating epicardial SHH signaling. However, it is
important to point out that our data does not directly validate
this pathway, which should be veriﬁed by future research.
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